Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $545.98M.
ENTERPRISE VALUE (EV)
$545.98M
REGENXBIO Inc.
Market Cap
$385.15M
Enterprise Value (EV)
$545.98M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| REGENXBIO Inc. (RGNX) | $385.15M | $545.98M |
| Orthofix Medical Inc. (OFIX)vs › | $380.37M | $511.18M |
| Zura Bio Limited (ZURA)vs › | $376.19M | $171.06M |
| Canopy Growth Corporation (CGC)vs › | $376.01M | $334.27M |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $374.50M | $375.69M |
| Shoulder Innovations, Inc. (SI)vs › | $396.93M | $387.32M |
| Carlsmed, Inc. (CARL)vs › | $397.99M | $373.66M |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $369.50M | $200.95M |
| Neurogene Inc. (NGNE)vs › | $402.17M | $298.03M |
| Myriad Genetics, Inc. (MYGN)vs › | $404.24M | $499.54M |
Market Cap
$385.15M
Total Debt
$195.30M
Cash
$34.47M
Enterprise Value
$545.98M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
